Tanya Lewis

This profile gathers the share dealings of Tanya Lewis across 3 companies, led by Replimune Group, Inc., Karyopharm Therapeutics Inc. and Vion Pharmaceuticals Inc. Between 10 December 2008 and 13 June 2023, the trades on record add up to 13 filings.

Sales make up the whole of the open-market record (6 sales, €595k). Other entries cover 5 share grants and 2 option exercises. 2023 to date brings no purchases and 3 sales.

The record was last updated on 15 June 2023 with an open-market sale (€18k) in Replimune Group, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.